Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by wofatson Aug 01, 2024 11:48am
125 Views
Post# 36158395

RE:RE:CPH acquired global rights to lice & scabies treatment

RE:RE:CPH acquired global rights to lice & scabies treatment

You did mean except for this one over the last 3 years if you were astute enough to buy between Dec.2020 and Dec2023.  Just sayin .
I do remember you posting you not own any Knight though . 
 

 

Second quarter results coming next week  There still is no volume on the stock .A few shares move the stock up and down and distort it .  I am still picking away.
 


 

YTD Return

GUD.TO
8.09%
S&P/TSX Composite index
8.51%

1-Year Return

GUD.TO
16.15%
S&P/TSX Composite index
10.25%

3-Year Return

GUD.TO
9.57%
S&P/TSX Composite index
12.09%

<< Previous
Bullboard Posts
Next >>